Bibliographic Details
| Title: |
Erythrodermic Psoriasis Managed with Risankizumab |
| Authors: |
Abdulmajeed Alajlan, Abdulaziz Madani, Tala Ammar Qadoumi, Alhanouf Aljaloud, Mohammed Alessa |
| Source: |
Case Reports in Dermatology, Vol 14, Iss 2, Pp 219-224 (2022) |
| Publisher Information: |
Karger Publishers, 2022. |
| Publication Year: |
2022 |
| Collection: |
LCC:Dermatology |
| Subject Terms: |
psoriasis, erythrodermic psoriasis, psoriasis treatment, biological therapy, risankizumab, erythroderma, Dermatology, RL1-803 |
| More Details: |
Erythrodermic psoriasis (EP) is a severe, often refractory, variant of psoriasis. Due to the high morbidity and mortality rate associated with EP and other causes of erythroderma, they are often classified as dermatologic emergencies. EP is usually a therapeutic challenge, where topical and conventional systemic therapies have yielded a less than satisfactory result in several patients. Furthermore, there are a limited number of studies evaluating other therapeutic modalities, such as biologic agents, with no clear treatment guidelines. In this case report, we present a patient who was diagnosed as a case of EP and showed an impressive response to risankizumab. |
| Document Type: |
article |
| File Description: |
electronic resource |
| Language: |
English |
| ISSN: |
1662-6567 |
| Relation: |
https://www.karger.com/Article/FullText/525774; https://doaj.org/toc/1662-6567 |
| DOI: |
10.1159/000525774 |
| Access URL: |
https://doaj.org/article/e545fc5039ce45d48f10c6f879e199d5 |
| Accession Number: |
edsdoj.545fc5039ce45d48f10c6f879e199d5 |
| Database: |
Directory of Open Access Journals |
